Lin B, Li Y, Wang T, Qiu Y, et al. CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK. Oncogene 2020 Aug 10. pii: 10.1038/s41388-020-01412.
PMID: 32778769